Literature DB >> 6823918

Kawasaki syndrome in the United States 1976 to 1980.

D M Bell, D M Morens, R C Holman, E S Hurwitz, M K Hunter.   

Abstract

Review of 523 confirmed cases of Kawasaki syndrome reported to the Centers for Disease Control (CDC), during the period from July 1976 through December 1980, disclosed a previously unrecognized seasonal variation, with a peak incidence between February and May. A significantly higher incidence in black children, compared with white children, was also noted. Earlier reports of a higher incidence in children younger than 5 years of age, males, and children of Asian ancestry were confirmed. Frequently reported complications included joint involvement (27%) and cardiac abnormalities (22%); 1.2% of patients died. Four outbreaks (mean duration, 3.8 months) were investigated by the CDC, but no evidence of person-to-person transmission or a point source of exposure was found. These data suggest that some cases may be caused by an exogenous agent or toxin that is most prevalent in the late winter and spring. In addition, host, environmental, or other cofactors are likely to be important determinants of susceptibility.

Entities:  

Mesh:

Year:  1983        PMID: 6823918     DOI: 10.1001/archpedi.1983.02140290003001

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  17 in total

1.  Recurrent Kawasaki disease resistant to initial treatment with intravenous immunoglobulin.

Authors:  Nader M Osman
Journal:  Sudan J Paediatr       Date:  2012

2.  A case-control study of recurrent Kawasaki disease using the database of the nationwide surveys in Japan.

Authors:  Y Nakamura; H Yanagawa
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

3.  Recurrent Kawasaki disease.

Authors:  T A Vargo; J C Huhta; W H Moore; D A Person; M S Edwards
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

Review 4.  Pharmacological therapy for patients with Kawasaki disease.

Authors:  R V Williams; L L Minich; L Y Tani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

5.  [Clinical features of children with recurrent Kawasaki disease: a Meta analysis].

Authors:  Gang Luo; Si-Lin Pan; Si-Bao Wang; Zhan-Hui DU; Zhi-Xian Ji
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-12

6.  Kawasaki syndrome.

Authors:  J Price
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-28

7.  Role of house dust mites in Kawasaki disease.

Authors:  A B Murray; R M Laxer; R E Petty; D P Speert
Journal:  Can Med Assoc J       Date:  1984-10-01       Impact factor: 8.262

8.  Kawasaki disease--Indian perspective.

Authors:  R N Pendse; H Bhandari; A K Vats; B Bhandari
Journal:  Indian J Pediatr       Date:  2001-08       Impact factor: 1.967

9.  Aortic and mitral regurgitation in an infant with Kawasaki disease.

Authors:  B J Freij; M Gessouroun; D E Fixler; C W Fink
Journal:  Pediatr Cardiol       Date:  1985       Impact factor: 1.655

10.  Evidence for a superantigen mediated process in Kawasaki disease.

Authors:  N Curtis; R Zheng; J R Lamb; M Levin
Journal:  Arch Dis Child       Date:  1995-04       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.